Patrick OBrien - Pardes Biosciences VP Relations
| PRDSDelisted Stock | USD 2.14 0.01 0.47% |
Insider
Patrick OBrien is VP Relations of Pardes Biosciences
| Phone | 415 649 8758 |
| Web | https://www.pardesbio.com |
Pardes Biosciences Management Efficiency
The company has return on total asset (ROA) of (0.2649) % which means that it has lost $0.2649 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4028) %, meaning that it created substantial loss on money invested by shareholders. Pardes Biosciences' management efficiency ratios could be used to measure how well Pardes Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| BSc FRCPath | Achilles Therapeutics PLC | 59 | |
| Karl MD | Achilles Therapeutics PLC | 57 | |
| FMEDSCI MD | Achilles Therapeutics PLC | 49 | |
| Claude MD | Ovid Therapeutics | 71 | |
| MBA BS | CytomX Therapeutics | 45 | |
| Erin Lavelle | Eliem Therapeutics | 47 | |
| Gregory Russotti | Century Therapeutics | 57 | |
| Mark Wallet | Century Therapeutics | N/A | |
| Jeffrey Rona | Ovid Therapeutics | 56 | |
| Osvaldo Flores | Century Therapeutics | 61 | |
| Michelle Doig | Nuvation Bio | 46 | |
| Michael Diem | Century Therapeutics | 53 | |
| Jason MBA | Ovid Therapeutics | 46 | |
| Gary Hattersley | Nuvation Bio | 57 | |
| Michael MSBA | NextCure | 63 | |
| MBA MD | Eliem Therapeutics | 63 | |
| BS CMAR | Champions Oncology | N/A | |
| Sandeep MD | Instil Bio | 55 | |
| Kathryn Falberg | Nuvation Bio | 60 | |
| DSc FACP | Ovid Therapeutics | 65 | |
| Robert Bazemore | Nuvation Bio | 53 | |
Management Performance
| Return On Equity | -0.4 | |||
| Return On Asset | -0.26 |
Pardes Biosciences Leadership Team
Elected by the shareholders, the Pardes Biosciences' board of directors comprises two types of representatives: Pardes Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pardes. The board's role is to monitor Pardes Biosciences' management team and ensure that shareholders' interests are well served. Pardes Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pardes Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Elizabeth JD, Gen Sec | ||
| Heidi CPA, Chief Officer | ||
| Dave Kuo, VP HR | ||
| Uri MD, Founder Director | ||
| Valdas Jurkauskas, VP Operations | ||
| Thomas Wiggans, CEO Chairman | ||
| Patrick OBrien, VP Relations | ||
| Sean Brusky, Chief Officer | ||
| Brian PharmD, Chief Officer | ||
| Ann Kwong, Ex Research |
Pardes Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pardes Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.4 | |||
| Return On Asset | -0.26 | |||
| Current Valuation | (22.1 M) | |||
| Shares Outstanding | 62.01 M | |||
| Shares Owned By Insiders | 13.47 % | |||
| Shares Owned By Institutions | 72.05 % | |||
| Number Of Shares Shorted | 874.35 K | |||
| Price To Book | 0.37 X | |||
| EBITDA | (99.82 M) | |||
| Net Income | (96.63 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |